Skip to main content
SpringerLink
Log in

Staging Systems

  • Chapter
  • First Online:
Hilar Cholangiocarcinoma

Abstract

Originally described by Altmeier [1] and Klatskin [2], hilar cholangiocarcinoma is an adenocarcinoma of the extrahepatic biliary tree arising from the main left or right hepatic ducts or their confluence. Along with distal bile duct cancer and intrahepatic cholangiocarcinoma, they comprise the spectrum of bile duct cancers that arise from the biliary epithelium. However, unlike those tumors, which can be usually be removed, respectively, with pancreaticoduodenectomy or liver resection alone, the surgical approach to hilar cholangiocarcinoma often combines bile duct resection with concomitant hepatectomy and/or portal vein resection due to the infiltrative nature of the disease. Therefore, a complete, margin-negative resection can be difficult to achieve.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Altemeier WA, Gall EA, Zinninger MM, et al. Sclerosing carcinoma of the major intrahepatic bile ducts. AMA Arch Surg. 1957;75(3):450–60; discussion 460–1.

    Article  PubMed  CAS  Google Scholar 

  2. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med. 1965;38:241–56.

    Article  PubMed  CAS  Google Scholar 

  3. Ito F, Cho CS, Rikkers LF, et al. Hilar cholangiocarcinoma: current management. Ann Surg. 2009;250(2):210–8.

    Article  PubMed  Google Scholar 

  4. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975;140(2):170–8.

    PubMed  CAS  Google Scholar 

  5. Madariaga JR, Iwatsuki S, Todo S, et al. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg. 1998;227(1):70–9.

    Article  PubMed  CAS  Google Scholar 

  6. Pitt HA, Dooley WC, Yeo CJ, et al. Malignancies of the biliary tree. Curr Probl Surg. 1995;32(1):1–90.

    Article  PubMed  CAS  Google Scholar 

  7. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224(4):463–73; discussion 473–5.

    Article  PubMed  CAS  Google Scholar 

  8. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg. 1992;215(1):31–8.

    Article  PubMed  CAS  Google Scholar 

  9. Launois B, Terblanche J, Lakehal M, et al. Proximal bile duct ­cancer: high resectability rate and 5-year survival. Ann Surg. 1999;230(2):266–75.

    Article  PubMed  CAS  Google Scholar 

  10. Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg. 1999;230(6):808–18; discussion 819.

    Article  PubMed  CAS  Google Scholar 

  11. Igami T, Nishio H, Ebata T, et al. Surgical treatment of hilar cholangiocarcinoma in the “new era”: the Nagoya University experience. J Hepatobiliary Pancreat Sci. 2010;17(4):449–54.

    Article  PubMed  Google Scholar 

  12. Hirano S, Kondo S, Tanaka E, et al. Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. J Hepatobiliary Pancreat Sci. 2010;17(4):455–62.

    Article  PubMed  Google Scholar 

  13. Miyazaki M, Kimura F, Shimizu H, et al. One hundred seven ­consecutive surgical resections for hilar cholangiocarcinoma of ­bismuth types II, III, IV between 2001 and 2008. J Hepatobiliary Pancreat Sci. 2010;17(4):470–5.

    Article  PubMed  Google Scholar 

  14. Unno M, Katayose Y, Rikiyama T, et al. Major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2010;17(4):463–9.

    Article  PubMed  Google Scholar 

  15. Greene FL, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging handbook: from the AJCC cancer staging manual. 6th ed. New York: Springer; 2002.

    Google Scholar 

  16. Fleming ID, American Joint Committee on Cancer, American Cancer Society, et al. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997.

    Google Scholar 

  17. Hong SM, Kang GH, Lee HY, et al. Smooth muscle distribution in the extrahepatic bile duct: histologic and immunohistochemical studies of 122 cases. Am J Surg Pathol. 2000;24(5):660–7.

    Article  PubMed  CAS  Google Scholar 

  18. Nishio H, Nagino M, Oda K, et al. TNM classification for perihilar cholangiocarcinoma: comparison between 5th and 6th editions of the AJCC/UICC staging system. Langenbecks Arch Surg. 2005;390(4):319–27.

    Article  PubMed  Google Scholar 

  19. Hong SM, Kim MJ, Pi DY, et al. Analysis of extrahepatic bile duct carcinomas according to the new American Joint Committee on cancer staging system focused on tumor classification problems in 222 patients. Cancer. 2005;104(4):802–10.

    Article  PubMed  Google Scholar 

  20. Hong SM, Cho H, Moskaluk CA, et al. Measurement of the invasion depth of extrahepatic bile duct carcinoma: an alternative method overcoming the current T classification problems of the AJCC staging system. Am J Surg Pathol. 2007;31(2):199–206.

    Article  PubMed  CAS  Google Scholar 

  21. Ebata T, Nagino M, Kamiya J, et al. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg. 2003;238(5):720–7.

    Article  PubMed  Google Scholar 

  22. Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg. 2005;242(3):451–8; discussion 458–61.

    PubMed  Google Scholar 

  23. Klempnauer J, Ridder GJ, von Wasielewski R, et al. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol. 1997;15(3):947–54.

    PubMed  CAS  Google Scholar 

  24. Kitagawa Y, Nagino M, Kamiya J, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg. 2001;233(3):385–92.

    Article  PubMed  CAS  Google Scholar 

  25. Deki H, Sato T. An anatomic study of the peripancreatic lymphatics. Surg Radiol Anat. 1988;10(2):121–35.

    Article  PubMed  CAS  Google Scholar 

  26. Shirai Y, Yoshida K, Tsukada K, et al. Identification of the regional lymphatic system of the gallbladder by vital staining. Br J Surg. 1992;79(7):659–62.

    Article  PubMed  CAS  Google Scholar 

  27. Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340(12):908–14.

    Article  PubMed  CAS  Google Scholar 

  28. House MG, Gonen M, Jarnagin WR, et al. Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg. 2007;11(11):1549–55.

    Article  PubMed  Google Scholar 

  29. Tepper JE, O’Connell MJ, Niedzwiecki D, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol. 2001;19(1):157–63.

    PubMed  CAS  Google Scholar 

  30. Schwarz RE, Smith DD. Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on U.S. Population data. J Gastrointest Surg. 2007;11(2):158–65.

    Article  PubMed  Google Scholar 

  31. Ito K, Ito H, Allen PJ, et al. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg. 2010;251(4):675–81.

    Article  PubMed  Google Scholar 

  32. Hong SM, Cho H, Lee OJ, et al. The number of metastatic lymph nodes in extrahepatic bile duct carcinoma as a prognostic factor. Am J Surg Pathol. 2005;29(9):1177–83.

    Article  PubMed  Google Scholar 

  33. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236(3):355–66; discussion 366–8.

    Article  PubMed  Google Scholar 

  34. Kawai M, Tani M, Kobayashi Y, et al. The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma. Am J Surg. 2010;199(4):447–52.

    Article  PubMed  Google Scholar 

  35. Oshiro Y, Sasaki R, Kobayashi A, et al. Prognostic relevance of the lymph node ratio in surgical patients with extrahepatic cholangiocarcinoma. Eur J Surg Oncol. 2011;37(1):60–4.

    Article  PubMed  CAS  Google Scholar 

  36. Sasaki R, Murata S, Oda T, et al. Evaluation of UICC-TNM and JSBS staging systems for surgical patients with extrahepatic cholangiocarcinoma. Langenbecks Arch Surg. 2010;395(6):615–23.

    Article  PubMed  Google Scholar 

  37. Jarnagin WR, Bowne W, Klimstra DS, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg. 2005;241(5):703–12; discussion 712–4.

    Article  PubMed  Google Scholar 

  38. Gazzaniga GM, Faggioni A, Filauro M. Surgical treatment of proximal bile duct tumors. Int Surg. 1985;70(1):45–8.

    PubMed  CAS  Google Scholar 

  39. Gazzaniga GM, Filauro M, Bagarolo C, et al. Surgery for hilar cholangiocarcinoma: an Italian experience. J Hepatobiliary Pancreat Surg. 2000;7(2):122–7.

    Article  PubMed  CAS  Google Scholar 

  40. Burke EC, Jarnagin WR, Hochwald SN, et al. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg. 1998;228(3):385–94.

    Article  PubMed  CAS  Google Scholar 

  41. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234(4):507–17; discussion 517–9.

    Article  PubMed  CAS  Google Scholar 

  42. Rocha FG, Matsuo K, Blumgart LH, et al. Hilar cholangiocarcinoma: the memorial sloan-kettering cancer center experience. J Hepatobiliary Pancreat Sci. 2010;17(4):490–6.

    Article  PubMed  Google Scholar 

  43. Hemming AW, Reed AI, Fujita S, et al. Surgical management of hilar cholangiocarcinoma. Ann Surg. 2005;241(5):693–9; discussion 699–702.

    Article  PubMed  Google Scholar 

  44. Ito F, Agni R, Rettammel RJ, et al. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg. 2008;248(2):273–9.

    Article  PubMed  Google Scholar 

  45. Zervos EE, Osborne D, Goldin SB, et al. Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach. Am J Surg. 2005;190(5):810–5.

    Article  PubMed  Google Scholar 

  46. Blechacz BR, Sanchez W, Gores GJ. A conceptual proposal for staging ductal cholangiocarcinoma. Curr Opin Gastroenterol. 2009;25(3):238–9.

    Article  PubMed  Google Scholar 

  47. Weston BR, Ross WA, Wolff RA, et al. Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: how soon should we repeat endoscopic retrograde cholangiopancreatography? Cancer. 2008;112(11):2417–23.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, 10027, USA

    F. G. Rocha MD

  2. Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, 10027, USA

    W. R. Jarnagin MD

Authors
  1. F. G. Rocha MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. R. Jarnagin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. R. Jarnagin MD .

Editor information

Editors and Affiliations

  1. , Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, N/A, Hong Kong SAR

    W.Y. Lau

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media Dordrecht and People's Medical Publishing House

About this chapter

Cite this chapter

Rocha, F.G., Jarnagin, W.R. (2013). Staging Systems. In: Lau, W. (eds) Hilar Cholangiocarcinoma. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6473-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-6473-6_4

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-007-6472-9

  • Online ISBN: 978-94-007-6473-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation